RYALTRIS
Updated 10 days ago
RYALTRIS is a combination of olopatadine, a histamine-1 (H1)-receptor inhibitor, and mometasone furoate, a corticosteroid, indicated for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older.
Also known as: Hikma Specialty USA, Hikma Specialty USA Inc